U.S. Advanced Wound Care OTC Market Size, Share & Trends Analysis Report By Product (Foam Dressings, Hydrocolloids Dressings, Hydrogel Dressings, Honey Dressings), By Application (Acute Wound, Chronic Wound), By Distribution Channel, And Segment Forecasts

U.S. Advanced Wound Care OTC Market Summary

The U.S. advanced wound care OTC market size was estimated at USD 2.77 billion in 2024 and is projected to reach USD 6.61 billion by 2033, growing at a CAGR of 10.33% from 2025 to 2033. The growth is driven by the increasing prevalence of acute wounds, such as surgical wounds, traumatic injuries, and burns, which require effective and immediate wound management solutions.

Rising rates of road accidents, sports injuries, and surgical procedures globally have led to a surge in demand for advanced OTC wound care products that promote faster healing and reduce the risk of infection. According to the data published by the Total Family Care Center in April 2025, approximately 11 million individuals in the U.S. experience acute wounds annually, with around 300,000 cases requiring hospital care. In addition, the growing awareness among consumers regarding proper wound care practices and the ease of access to advanced dressings through retail pharmacies and online platforms continue to support market expansion.

The high and rising prevalence of diabetes in the U.S. significantly drives the growth of the market. Diabetes is a significant risk factor for the development of chronic wounds, particularly diabetic foot ulcers, which require timely and effective wound management to prevent complications such as infections and amputations. For instance, the Centers for Disease Control and Prevention (CDC) reports that more than 38 million Americans have diabetes (about 1 in 10), and about 90% to 95% of them have type 2 diabetes.

There is an increasing demand for accessible, over-the-counter wound care products that allow individuals to manage minor wounds and prevent them from worsening. Advanced OTC wound care solutions offer diabetic patients a convenient way to treat wounds at home, reducing the need for frequent clinical visits. This growing need for self-care solutions among the diabetic population is a key factor propelling the expansion of the U.S. advanced wound care OTC industry.

U.S. Advanced Wound Care OTC Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. advanced wound care OTC market report based on product, application, and distribution channel.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Foam Dressings
• Adhesive
• Non-adhesive Foam Dressings
• Film Dressings
• Hydrocolloids
• Hydrogel Dressings
• Honey Dressings
• Greasy Gauzes
• Non-Woven Post Operative Dressings
• Others
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Chronic Wounds
• Diabetic Foot Ulcers
• Pressure Ulcers (Stage 1, Stage 2, Stage 3, Stage 4, and Deep Tissue Injury included)
• Venous Leg Ulcers
• Other Chronic Wounds
• Acute Wounds
• Surgical & Traumatic Wounds (skin tears included)
• Burns
• 1st degree burns
• 2nd degree burns
• 3rd degree burns
• Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
• Retail Pharmacies / Drugstores
• E-commerce/Online Pharmacies / Health E-tailers
• Others